Previous Article | Next Article 
Journal of Clinical Microbiology, February 2001, p. 445-453, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.445-453.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Relatedness of Streptococcus suis
Isolates of Various Serotypes and Clinical Backgrounds as Evaluated by
Macrorestriction Analysis and Expression of Potential Virulence
Traits
Achim
Allgaier,1
Ralph
Goethe,1
Henk J.
Wisselink,2
Hilde E.
Smith,2 and
Peter
Valentin-Weigand1,*
Institut fuer Mikrobiologie und Tierseuchen,
Tieraerztliche Hochschule Hannover, Hannover,
Germany,1 and Department of
Bacteriology, Institute for Animal Science and Health, Lelystad, The
Netherlands2
Received 14 July 2000/Returned for modification 29 September
2000/Accepted 7 November 2000
 |
ABSTRACT |
We evaluated the genetic diversity of Streptococcus
suis isolates of different serotypes by macrorestriction analysis
and elucidated possible relationships between the genetic background, expression of potential virulence traits, and source of isolation. Virulence traits included expression of serotype-specific
polysaccharides, muramidase-released protein (MRP), extracellular
protein factor (EF), hemolysin activity, and adherence to epithelial
cells. Macrorestriction analysis of streptococcal DNA digested with
restriction enzymes SmaI and ApaI allowed
differentiation of single isolates that could be assigned to four major
clusters, named A1, A2, B1, and B2. Comparison of the genotypic and
phenotypic features of the isolates with their source of isolation
showed that (i) the S. suis population examined, which
originated mainly from German pigs, exhibited a genetic diversity and
phenotypic patterns comparable to those found for isolates from other
European countries; (ii) certain phenotypic features, such as the
presence of capsular antigens of serotypes 2, 1, and 9, expression of
MRP and EF, and hemolysin activity (and in particular, combinations of
these features), were strongly associated with the clinical background
of meningitis and septicemia; and (iii) isolates from pigs with
meningitis and septicemia showed a significantly higher degree of
genetic homogeneity compared to that for isolates from pigs with
pneumonia and healthy pigs. Since the former isolates are considered
highly virulent, this supports the theory of a clonal relationship
among highly virulent strains.
 |
INTRODUCTION |
Streptococcus suis is a
major cause of meningitis, septicemia, arthritis, and bronchopneumonia
in young pigs and can cause meningitis in humans (1, 2).
Effective control of the disease is hampered by the poor knowledge
about its epidemiology and pathogenesis. Since many healthy pigs harbor
S. suis as an "early colonizer" (6, 18),
identification of virulent S. suis isolates is of particular
importance. This is, however, complicated by the pathogen's extreme
diversity, in particular with respect to its virulence.
Phenotypic markers used to distinguish highly virulent and avirulent
isolates include the presence of serotype-specific capsular polysaccharides (25), expression of muramidase-relased
protein (MRP) (27, 35) and extracellular protein factor
(EF) (35), and hemolysin activity (10, 11,
16). The role of these factors as virulence markers, however, is
still unclear. The capsular polysaccharides are the basis for
classification into serotypes (of which 35 are currently known) and
have recently been shown to prevent phagocytosis and, thus, have been
proposed as an important virulence trait (25). Serotype 2 is considered the most dominant one among highly virulent strains, but
disease is also frequently caused by strains of other serotypes
(24, 33, 36), suggesting that serotype-independent
virulence markers must exist. MRP and EF have previously been found to
be strongly associated with highly virulent isolates in Europe
(35, 36) but do not appear to confer virulence
directly, as recently demonstrated by the use of gene knockout
technology (28). Hemolysin activity has been characterized and associated with virulent strains, but its in vivo
expression does not seem to correlate with virulence (11, 12,
15). Adherence to epithelial cells has also been suggested as a
virulence trait (9), and adhesins that recognize
erythrocytes have been found to induce opsonizing antibodies in mice
(32). However, studies with adhesins were limited to a
very few strains, and information concerning the adherence mechanisms
and the possible role of adhesins in the virulence of the bacterium is
yet very poor.
Different molecular typing methods such as ribotyping have been
evaluated in comparison with conventional phenotyping, indicating that
the latter is of limited value for epidemiological analyses (12,
21, 23, 25, 29). Results of these studies also revealed an
association between virulence and ribotype, thus demonstrating that a
close relationship between highly virulent strains is plausible (23, 26, 29). Nevertheless, most of these studies were
restricted to serotype 2 isolates, and the hypothesis about a clonal
lineage or relationship of highly virulent strains is still under
debate (4, 12, 13, 19).
The purpose of the present study was to elucidate the genetic diversity
within an S. suis population belonging to various serotypes,
particularly by comparing isolates from pigs with invasive disease,
i.e., meningitis and septicemia, versus isolates from pigs with
pneumonia and healthy pigs. For this, we studied a collection of 99 isolates, mostly recovered from German pigs, by assessing possible
relationships between the genetic background, different phenotypic
markers (serotype, expression of MRP and EF, hemolysin activity,
adherence to epithelial cells), and clinical backgrounds.
 |
MATERIALS AND METHODS |
If not stated otherwise, all chemicals were purchased from Sigma
(Munich, Germany).
Bacteria.
S. suis isolates had been randomly
collected in the course of routine diagnostic procedures from tissues
of healthy and diseased pigs over a period of 3 years (1996 to 1998).
Most pigs were 4 to 12 weeks old and from different farms located in
different geographic regions in (especially northern) Germany.
According to the source of isolation and clinical background, the
isolates were assigned to three groups, i.e., (i) those from pigs with meningitis, septicemia, or arthritis (isolates from brains and joints
of animals with respective clinical symptoms [also referred to as
meningitis-septicemia isolates]), (ii) those from pigs with pneumonia
(S. suis was isolated from lungs, either as a pure culture [40% of all pneumonia isolates] or in association with other
respiratory pathogens such as Pasteurella spp. and
Bordetella bronchiseptica [60% of all pneumonia
isolates]), and (iii) those from healthy pigs (isolated from swabs of
the upper respiratory or the genital tract). For comparison purposes, a
number of reference and control strains were included, such as the
suilysin control strain P1/7 described by Jacobs et al.
(15), serotype 2 reference strain Henrichsen S735 (DSM
9682; German Culture Collection, Braunschweig, Germany), serotype 1 reference strain Henrichsen S428 (DSM 9683), and MRP-EF control strains
D282, T15, and 4005 (34). Bacteria were isolated on blood
agar plates, identified as S. suis by standard biochemical
testing, and cultured in Todd-Hewitt broth (Oxoid, Wesel, Germany), on
blood agar plates, or on tryptic soy agar plates for 18 h at
37°C.
Phenotyping. (i) Serotyping and expression of MRP and EF.
Serotyping and determination of expression of MRP and EF were done as
described previously (33). Serotype-specific antisera had
been prepared in rabbits (8) against reference strains of
serotypes 1 to 28.
(ii) Hemolysin activity.
Determination of hemolysin activity
was done as described by Staats et al. (29), with some
minor modifications. Briefly, streptococci from an overnight plate
culture on tryptic soy agar were washed and suspended in
phosphate-buffered saline (PBS) to an optical density (OD) at 560 nm of
1.6. The suspensions were incubated for 1 h at 40°C to optimize
hemolysin production and centrifuged, and the supernatants were
immediately tested for hemolysin activity by using 1% sheep
erythrocytes in PBS. Tests were run in round-bottom 96-well microtiter
plates as twofold serial dilutions beginning with 100 µl of
supernatant. A total of 100 µl of erythrocytes was added to each
dilution. After incubation for 2 h at 37°C in 6%
CO2, the plates were centrifuged and the supernatants were
transferred to a new plate for spectrophotometric measurements at 410 nm. As controls, streptococcal supernatants were replaced by PBS
(negative control) or H2O (positive control). Each
experiment was run in triplicate and included a freshly prepared supernatant of hemolysin control strain P1/7 as an internal reference. Results were expressed as mean relative hemolysin activity as a
percentage of the activity expressed by strain P1/7. According to the
resulting activities, the isolates were grouped as hemolysin negative
(<10% of the hemolysin activity of P1/7), intermediate (10 to 80% of
the hemolysin activity of P1/7), or positive (>80% of the hemolysin
activity of P1/7).
(iii) Adherence to epithelial cells.
Adherence to epithelial
cells was tested as described previously (31) by using
human HEp-2 cells (ATCC CCL23) and a porcine testis epithelial cell
line (kindly supplied by G. Herrler, Institut fuer Virologie,
Tieraerztliche Hochschule Hannover) grown to confluency on glass
coverslips. Approximately 100 streptococci per epithelial cell were
incubated for 1 h at 37°C. After three washes with PBS, the
coverslips were stained with Giemsa and examined microscopically by
counting the number of adherent streptococci per 50 epithelial cells.
The results were expressed as adherence negative (<25 adherent bacteria), intermediate (25 to 100 adherent bacteria), or positive (>100 adherent bacteria).
PFGE.
Macrorestriction analysis by pulsed-field gel
electrophoresis (PFGE) was done by using a modification of the method
of Olsen and Skov (22). Streptococcal DNA was prepared
from 18-h cultures in Todd-Hewitt broth. After centrifugation of the
cultures, the pelleted bacteria were washed and adjusted to an OD at
576 nm of 0.3 with PFGE buffer (1 M NaCl, 10 mM EDTA, 10 mM Tris-HCl [pH 8.0]). Five milliliters of this suspension was pelleted, washed once in PFGE buffer, resuspended in 0.5 ml of PFGE buffer, mixed with
0.5 ml of low-melting-temperature high-purity agarose (1.2%; Bio-Rad,
Munich, Germany), and subsequently aliquoted into 100-µl portions and
placed into a plug mold. After solidification, five plugs each were
placed in 3 ml of fresh lysis buffer (1 M NaCl, 200 mM EDTA, 10 mM
Tris-HCl [pH 8.0], 0.5% sarcosyl, 0.2% sodium deoyxycholate, 1 mg
of lysozyme per ml, 2 µg of RNase per ml, 13 U of mutanolysin per
ml). After incubation for 2 h at 37°C, the lysis solution was
replaced by 3 ml of ESP buffer (0.5 M EDTA, 1% sarcosyl, 1 mg of
proteinase K per ml) and further incubated overnight at 56°C.
Subsequently, the plugs were washed with TE buffer (10 mM Tris-HCl [pH
8.0], 1 mM EDTA) and incubated twice in TE buffer containing 1 mM
phenylmethylsulfonic acid fluoride for 30 min at room temperature. Then
the plugs were washed three times for 30 min each time with 3 ml of TE
buffer. After the final washing, 5 ml of TE buffer was added and the
plugs were stored overnight at 4°C. For digestion with the
restriction enzymes SmaI and ApaI (Boehringer
Mannheim, Mannheim, Germany), approximately 0.5-mm slices of the plugs
were cut and equilibrated in 250 µl of restriction enzyme reaction
buffer (as supplied by the manufacturer). After 1 h of
equilibration at room temperature, the buffer was replaced by 50 µl
of freshly prepared restriction enzyme reaction buffer containing 10 U
of SmaI or ApaI per ml. After incubation for
4 h at 37°C, the resulting DNA fragments were separated by PFGE
for 14 h (SmaI digestion) or 18 h (ApaI
digestion) at 6 V/cm with a CHEF DR II apparatus (Bio-Rad).
Subsequently, the bands were visualized by staining of the gels with
ethidium bromide and documented under UV illumination with (the
MulitAnalyst system (Bio-Rad).
Analysis of PFGE patterns.
Fragment sizes were calculated
for each lane by comparison with a size standard
(ApaI-digested genomic DNA from Staphylococcus aureus strain DSM 1104 [German Culture Collection]) which was run in parallel in each experiment. Bands of less than 50 kb were not
included to avoid possible interference of plasmid DNA. On the basis of
the calculated sizes of the resulting DNA fragments, the gels were
analyzed with GelCompar software (Applied Maths, Kortrijr, Belgium,
supplied by HeroLab, Wiesloch, Germany). Dendrograms were generated by
using the Dice coefficient, and clustering was done by the unweighted
pair group method with arithmetic averages (UPGMA) with a 3% tolerance
in band size.
Statistical analysis.
The statistical significance of
probabilities of dependences between different phenotypes, assignment
to PFGE clusters, and clinical backgrounds was analyzed by linear
regression (odds ratio) by the chi-square test. P values of
less than 0.01 were considered significant.
 |
RESULTS |
Macrorestriction analysis.
Macrorestriction analysis was done
by PFGE of streptococcal DNA digested with restriction enzymes
SmaI and ApaI. The number of bands obtained with
SmaI-digested DNA ranged from 6 to 13, and the number of
bands obtained with ApaI-digested DNA ranged from 15 to 23. Genome sizes calculated by addition of DNA fragments of various sizes
varied; for most isolates a genome size of 1.4 × 106
to 2.0 × 106 bp was calculated. This corresponded to
the genome size of streptococci as indicated in the literature
(30) (additional details can be found at the genome
website University of Oklahoma's Advanced Center for Genome
Technology (http://www.genome.ou.de/strep.html). Representative
PFGE gels of SmaI-digested DNAs of isolates mainly belonging
to serotype 9 are shown in Fig. 1A, and
PFGE gels of ApaI-digested DNAs of isolates mainly belonging
to serotype 2 are shown in Fig. 1B. The data show that PFGE allowed
differentiation of isolates between and within serotypes. Moreover,
PFGE enabled us to monitor isolates from various locations of a single
animal (Fig. 1A, lanes 11 and 12; Fig. 1B, lanes 17 to 19) as well as from different animals within the same herd (Fig. 1A, lanes 10, 16, and
20). Strongly related but not identical isolates could also easily be
discriminated (Fig. 1A, lanes 21 and 22; Fig. 1B, lanes 20 to 24).
Cluster analysis of PFGE patterns of SmaI-digested DNA by
UPGMA revealed a dendrogram with four major groups, designated groups
A1, A2, B1, and B2, each comprising isolates with a similarity of at
least 20% (Fig. 2). Isolates which
appeared to be identical by visual inspection of the gels showed
similarities of approximately 80 to 100% by cluster analysis. Examples
are isolates I9841/1-3 (Fig. 2, cluster A1, corresponding to Fig. 1B,
lanes 17 to 19) as well as isolates A3313/1/98 and A3313/3/98 (Fig. 2,
cluster B1, corresponding to Fig. 1A, lanes 11 and 12). Closely related isolates showed similarities of approximately 70% by cluster analysis, e.g., strains P1/7 and D282 (Fig. 2, cluster A1, corresponding to Fig.
1A, lanes 21 and 22), as well as isolates B422/97 and 631/97 (Fig. 2,
cluster A2, corresponding to Fig. 1B, lanes 14 and 15). All isolates
determined to be closely related by PFGE with SmaI-digested
DNA could be more clearly differentiated visually in PFGE gels of
ApaI-digested DNA (data not shown). A dendrogram constructed
from the PFGE patterns of ApaI-digested DNA was almost similar to the dendrogram constructed from the PFGE patterns of SmaI-digested DNA, except that the degree of differentiation
was higher (data not shown).

View larger version (125K):
[in this window]
[in a new window]
|
FIG. 1.
Macrorestriction analysis of S. suis isolates
by PFGE. (A) PFGE of SmaI-digested DNA of S. suis
serotype 9 isolates (lanes 1 to 20 and 23) and, in addition, serotype 2 hemolysin activity-positive control strain P1/7 (lane 21) and serotype
2 MRP- and EF-positive control strain D282 (lane 22). Lane M, size
standard (ApaI-digested genomic DNA from S. aureus strain DSM 1104) indicating molecular sizes (in kilobases).
(B) PFGE of ApaI-digested DNA of S. suis serotype
2 isolates (lanes 1 to 24) including the type 2 reference strain (lane
5), MRP- and EF-positive control strains 4005 (lane 7), T15 (lane 8),
and D282 (lane 23), as well as hemolysin activity-positive control
strain P1/7 (lane 20). Lane M, size standard (ApaI-digested
genomic DNA from S. aureus, strain DSM 1104) indicating
molecular sizes (in kilobases).
|
|

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 2.
Dendrogram of similarity among the observed PFGE
macrorestriction patterns of SmaI-digested DNAs from 99 S. suis isolates. Serotypes (ST) and clinical backgrounds
(CB) are indicated on the right. Isolates originated either from pigs
with typical invasive disease (meningitis [M], septicemia [S],
arthritis [A]), from pigs with pneumonia (P), or from healthy pigs
(H). Major clusters are indicated by A1, A2, B1, and B2. nt,
nontypeable.
|
|
Comparison of the clinical backgrounds of isolates with their
assignment to the different clusters revealed that 20 of 48
isolates
from pigs with meningitis-septicemia belonged to cluster
A1 (Table
1). In contrast, isolates from pigs with
pneumonia
or from healthy pigs were almost equally distributed among
the
different clusters except for cluster A1 (Table
1). The phenotypic
features of the cluster A1 isolates are described below.
Serotyping and analysis of potential virulence traits.
Results
from serotyping and phenotyping of isolates are summarized in Tables 2
to 4. The distribution of serotypes within the different isolates shows
that the majority belonged to serotypes 2 (25%) and 9 (20%), followed
by serotypes 3, 7, 1/2, 5, 4, and 1 (Table
2). The remaining isolates (indicated as
"others" in Table 2) either belonged to serotype 8, 15, 16, or 25 or were nontypeable with the antisera used (i.e., antisera to serotypes 1 to 28). The nontypeable isolates represented 7% of the total number
tested. The most dominant serotypes among all isolates tested,
serotypes 2 and 9, also represented the majority of isolates from pigs
with meningitis-septicemia (44% were serotype 2, 25% were serotype
9), followed by serotype 1 (8% of all meningitis-septicemia isolates)
(Table 2). On the other hand, the serotypes of isolates from pigs with
pneumonia showed a broader distribution, with most of these isolates
belonging to serotype 3, 5, 7, or 9 (Table 2). Interestingly, most
isolates from healthy pigs were nontypeable or belonged to one of the
rarely represented serotypes (both indicated as "others" in Table
2).
Analysis of expression of virulence-associated proteins MRP and EF
(summarized in Table
3) demonstrated that
the majority
(67%) of all isolates expressed MRP, either alone or in
combination
with expression of EF. None of the isolates expressed
solely EF.
Isolates from pigs with meningitis-septicemia mostly either
expressed
MRP alone (52%) or expressed MRP in combination with EF
(29%).
Among isolates from pigs with pneumonia, only one expressed MRP
and EF; the remaining isolates expressed either MRP only (52.5%)
or
neither of these proteins (45%). All isolates were also tested
for
hemolysin activity, another potential virulence marker. The
results are
shown in Table
4. Isolates were
classified as hemolysin
negative, intermediate, or positive with
respect to their relative
activity in comparison with the activity of
control strain P1/7
(see Materials and Methods). A high proportion of
all isolates
were hemolysin negative (50%); only 27% were positive,
and 22%
were intermediate. This distribution was comparable among
isolates
from pigs with meningitis-septicemia and healthy pigs, whereas
a significantly higher proportion (95%) of isolates from pigs
with
pneumonia were hemolysin negative or intermediate. Adherence
of
streptococci to epithelial cells was tested since adherence
capacity
and/or presence of adhesins has been related to the virulence
of
S. suis (and other bacteria) in earlier studies (
10,
32).
Surprisingly, the adherence of all isolates to two commonly
used
cell lines, porcine testis cells and human HEp-2 epithelial cells,
was generally very low. Substantial adherence was observed for
only
25% of all isolates by using porcine cells and only 18% of
all
isolates by using HEp-2 cells. The isolates that adhered well
to HEp-2
cells were the same ones that adhered well to porcine
cells. There was
no association of adherence capacities with source
of isolation (data
not shown).
Taken together, these results showed that certain phenotypic features
were striking among isolates from pigs with meningitis-septicemia,
such
as the presence of capsular antigens of serotypes 2 and 9,
expression
of MRP and EF, and hemolysin activity. A more heterogeneous
background
seemed to exist within isolates from pigs with pneumonia
or healthy
pigs.
Relation of individual features of the isolates with clinical
background.
We next calculated the probabilities that isolates
with certain features, alone or in combination with each other,
originated from pigs with meningitis-septicemia, which would indicate a
high degree of virulence. A meningitis-septicemia background was found among 4 of the 5 serotype 1 isolates, 21 of the 25 serotype 2 isolates,
and 12 of the 19 serotype 9 isolates (Table 2), indicating a high
probability that isolates of serotypes 2 and 1 and, to a lesser extent,
of serotype 9 originated from pigs with meningitis. On the other hand,
most isolates belonging to serotypes 1/2 (five of eight), 3 (eight of nine), 4 (four of six), 5 (five of seven), or 7 (five of
eight) were from pigs with pneumonia; most isolates designated
"others" originated from healthy animals (Table 2). We also found a
very high probability of the clinical background meningitis-septicemia
among isolates expressing MRP and EF and hemolysin-positive isolates:
14 of the 15 MRP- and EF-positive isolates and 21 of the 27 hemolysin-positive isolates were from pigs with meningitis-septicemia
(Tables 3 and 4). Interestingly, a high proportion of isolates that
lacked hemolysin activity (25 of 50) or that expressed intermediate
hemolysin activity (13 of 22) had been isolated from pigs with
pneumonia (Table 4). Moreover, the majority of isolates of PFGE cluster
A1 (20 of 26) had a meningitis-septicemia background, and most isolates
of cluster B2 (11 of 19) were from pigs with pneumonia (Table 1). Taken
together, these data show that there was a high probability that
isolates exhibiting either the feature serotype 2 or serotype 1 capsular antigen expression, expression of MRP and EF, strong hemolysin
activity, or assignment to PFGE cluster A1 had a clinical background of
meningitis-septicemia. On the other hand, the features serotype 3, 4, or 5 capsular antigen expression and a lack of or intermediate
hemolysin activity indicated a high probability of pneumonia as the
clinical background.
The probability of the clinical background meningitis-septicemia was
even higher when some of the features mentioned above
were found in
combination (Fig.
3). We found that of
all serotype
2 isolates, 52% also expressed MRP and EF, 56% were
hemolysin
positive, and 56% belonged to cluster A1. All serotype 2 isolates
that were either MRP and EF positive or hemolysin positive as
well as 93% of the serotype 2 isolates assigned to cluster A1
originated from pigs with meningitis (Fig.
3A). Of the MRP- and
EF-positive isolates, 52% belonged to serotype 2, 67% were hemolysin
positive, and 67% belonged to cluster A1, and all isolates with
any of
these combinations had been isolated from pigs with
meningitis-septicemia
(Fig.
3B). Features of the hemolysin-positive and
cluster A1 isolates
in relation to the clinical background
meningitis-septicemia are
partially included in Fig.
3A and B but are
also shown separately
in Fig.
3C and D, respectively.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of combinations of different features of
S. suis isolates with their clinical backgrounds. Additional
features of serotype 2 isolates (A), isolates expressing MRP and EF
(MRP/EF isolates) (B), hemolysin-positive isolates (Hly isolates) (C),
and cluster A1 isolates (A1 isolates) (D) are shown. The leftmost pair
of bars in each graph (labeled Total) refers to all isolates expressing
the indicated feature; labeling of the remaining pairs of bars
indicates the additional feature found in isolates of the respective
group. Each pair of bars shows the proportion of isolates from pigs
with meningitis-septicemia (gray bars) compared to the total proportion
of isolates with this combination of features (black bars). Results are
expressed as a percentage of the total number for each group (N), which
is indicated in boxes above the respective groups.
|
|
Taken together, the probability of having a clinical background of
meningitis-septicemia was highest (100%) among isolates
with a
combination of serotype 2 with MRP and EF positivity or
hemolysin
activity, of MRP and EF positivity with hemolysin activity
or
assignment to cluster A1, and of hemolysin activity with assignment
to
cluster A1. In addition, there was a striking correlation of
serotypes
7 and 9 with a certain MRP-EF pattern, in that none
of these isolates
expressed EF. Furthermore, none of the serotype
7 isolates expressed
MRP, whereas all but one of the serotype
9 isolates expressed MRP, but
most of these expressed a size variant
of MRP (37). Only
two (10%) of all serotype 9 isolates were hemolysin
positive. Most
serotype 9 isolates were clustered in clusters
A2 and B1 (35% each).
Only one of the five serotype 1 isolates
expressed MRP and EF (the
other four isolates were negative for
both), and all were positive for
hemolysin activity. There was
no specific combination of features that
was strongly associated
with a background of pneumonia. Furthermore,
there was no association
of adherence capacity with a certain other
feature.
 |
DISCUSSION |
S. suis is a major pathogen in swine and can also
infect humans. The presence of S. suis in pigs, however, is
not a good indicator of disease, since carrier rates of this "early
colonizer" can be up to 100%, with prevalences of disease generally
being not more than 5% (5, 20). This indicates that the
level of virulence varies extremely between strains. Therefore, many
recent studies have been aimed at the identification of phenotypic
and/or genotypic virulence markers which might be useful to distinguish
virulent from less virulent or avirulent isolates (23, 26, 29,
35). As with many other pathogens, a single marker that is
sufficient for the identification of all highly virulent strains has
not yet been identified (and probably does not exist), but there is strong evidence that highly virulent strains share certain features and
might be more related than others (4, 21, 23, 26). Some of
these virulence-associated features seem to be production of
serotype-specific capsular polysaccharides (25),
expression of proteins MRP and EF (35), and expression of
hemolysin activity and suilysin (10, 17, 18). However, on
the basis of the high prevalence of serotype 2 isolates, most studies
have been restricted to serotype 2. Furthermore, some results might
have been overinterpreted with respect to the terms virulent and
avirulent, as recently discussed by Gottschalk et al. (M. Gottschalk,
R. Higgins, and S. Quessy. Letter, J. Clin. Microbiol.
37:4202-4203, 1999).
The ongoing debate about the relatedness of highly virulent strains and
the poor knowledge about the features of the S. suis population in Germany prompted us to perform the present study, in
which we characterized a collection of 99 S. suis isolates including some of the major reference strains. Isolates were first serotyped to ensure that serotypes other than serotype 2 were also
represented. The results of serotyping correlate well with those of
others (7), in that serotypes 2 and 9 are the dominant serotypes in most European countries except the United Kingdom, where
serotype 1 is most prevalent. Furthermore, we showed that other
serotypes such as 1, 1/2, 3, 4, 5, and 7 seem to be quite common
in the German S. suis population, which is in agreement with
recently published data (36).
Nearly half (48 of 99) of the isolates analyzed for the present study
originated from pigs with typical signs of disease (meningitis, septicemia, arthritis [referred to below as "typical isolates"]); 40 isolates were from pigs with pneumonia. In contrast to the importance of S. suis as a primary pathogen in pigs with
meningitis, septicemia, or arthritis, it's causative role in pneumonia
is not as clear since in many cases S. suis is isolated
together with other lung pathogens such as Pasteurella spp.,
B. bronchiseptica, or Mycoplasma spp.
(18, 24). Similarly, in our study only 16 of 40 S. suis isolates from pigs with pneumonia were isolated as pure
cultures. In agreement with the current knowledge of the pathogenicity
of S. suis (14, 18, 24), we therefore assumed that the isolates from pigs with typical signs (i.e., meningitis, etc.)
represented the most virulent strains, whereas isolates from pigs with
pneumonia were less invasive and, thus, less virulent. The remaining 11 of the 99 isolates studied were from healthy pigs and therefore
represented strains from carriers. Certainly, it must be considered
that the origin of isolation can only give some hints as to an
isolate's capacity to cause disease but is never proof of an
isolate's virulence.
Taking this into account, we analyzed three S. suis
subpopulations (i.e., typical isolates, isolates from pigs with
pneumonia, and isolates from potential carriers) by examining all
currently known putative virulence traits including adherence to
epithelial cells. In addition, all isolates were genotyped by
macrorestriction analysis by PFGE, a technique with a high resolution
power which hitherto has not been applied to S. suis. In our
hands, this technique proved to be most suitable for differentiation of
single isolates, even those of the same serotype within an infected
herd, and thus should be most valuable in epidemiological studies with
S. suis. Due to the high degree of sensitivity and the
discriminatory power of this technique, however, isolates that appeared
to be identical by visual inspection could also be found in very
closely related instead of identical branches after cluster analysis.
Therefore, it seemed reasonable to define a cutoff value for identity
(i.e., >80%) to exclude possible overinterpretation of
differentiation of two isolates.
The most prominent features among the typical isolates were the
presence of capsular antigens of serotype 2, 9, or 1, expression of MRP
and/or EF, and strong hemolysin activity. However, these features were
found in only about half of this population; the remaining isolates had
more heterogeneous backgrounds, suggesting that their virulence is
attributed to other characteristics. PFGE and subsequent cluster
analysis confirmed these assumptions, since most of the isolates
exhibiting one more of these most prominent features were found in one
cluster (cluster A1), whereas the others were more homogeneously
distributed in the resulting dendrogram. A different picture was seen
in isolates from pigs with pneumonia: serotype 2 was rarely found, and
in addition to serotype 9, serotypes 3, 5, and 7 were most prominent.
Moreover, only one of the isolates from pigs with pneumonia expressed
both MRP and EF, and only two isolates from pigs with pneumonia
expressed strong hemolysin activity. This might suggest a lower
capacity of isolates from pigs with pneumonia to express virulence
properties, which would correlate well with the assumption that
isolates from pigs with pneumonia are less invasive and virulent than
the typical isolates. No significant clustering of the isolates from
pigs with pneumonia was found by cluster analysis. This indicates that
the isolates from pigs with pneumonia had more heterogeneous phenotypic
and genotypic backgrounds than typical isolates. Among the isolates
from healthy animals that were potential carriers, the high proportion
(55%) of rarely seen serotypes and nontypeable isolates was most
striking, as was the high proportion (36%) of hemolysin-positive
isolates. This suggests that S. suis strains from carriers
are more diverse than virulent strains, but this must be confirmed by
analysis of a larger population of isolates.
A surprising finding of the present study was that adherence to
epithelial cells was not correlated at all to the clinical backgrounds
of the isolates, independent of the epithelial cell type used (human or
porcine). This raises the question of the significance of adherence as
a virulence trait, as suggested by others (9, 32). An
explanation for the poor adherence observed in our study might be
either that adherence is in fact no virulence trait or that a more
specific detection of adhesins is needed to evaluate the virulence
potential of a given strain or isolate. Concerning the latter, other
target cell types (e.g., porcine tonsillar epithelial or endothelial
cells) and/or different conditions for bacterial cultivation might have
to be tested. In addition, possible inhibitory effects of encapsulation
on adherence might have to be ruled out in future studies, even though
recently published data by Charland et al. (3) did not
support an inhibitory role of the capsule in adherence.
As described above, the phenotypic and genotypic backgrounds of the
isolates from diseased pigs revealed some variety but also confirmed
features that were commonly found. Therefore, we analyzed our data with
respect to the probabilities that the commonly found features, alone or
in combination with others, were associated with the clinical
background. The results showed that certain combinations of features
such as the presence of the capsular antigen of serotype 2 and
expression of MRP and EF or the presence of the capsular antigen of
serotype 2 and strong hemolysin activity were highly correlated with
the invasive clinical background meningitis-septicemia. Furthermore,
the probability of such a clinical background was even higher when
isolates expressing one of those features could be assigned to PFGE
cluster A1. In agreement with the findings of others on the specific
ribotype profiles of virulent strains and isolates (21,
29), our clustering results strongly support the hypothesis of a
relatively conserved genetic background of highly virulent strains.
Together with our observations on the serotypes and potential virulence
traits of the isolates tested, these data could indicate that certain
highly virulent clones have established themselves successfully within
the European S. suis population.
In conclusion, we have presented evidence that (i) PFGE analysis is a
most valuable tool for epidemiological studies of S. suis,
(ii) several known and yet unknown virulence traits exist in S. suis which, when combined, can give important hints as to whether
a given isolate is highly virulent, and (iii) highly virulent isolates
or strains from pigs with clinical backgrounds of invasive disease seem
to be more related than isolates from pigs with the less invasive
pneumonia or typical isolates from carriers. This raises the
perspective that in the near future it should be possible to develop
strategies for rapid identification of highly virulent isolates and for
monitoring of the epidemiology of S. suis infections.
 |
ACKNOWLEDGMENTS |
We are in debt to L. Kreienbrock and R. Meyer (Tieraerztliche
Hochschule Hannover) for excellent help with statistical analyses and
S. Schwarz (FAL, Celle, Germany) for great support with PFGE. We also
thank G. Amtsberg and M. Ganter (both from the Tieraerztliche Hochschule Hannover) and C. Laemmler (FB Veterinaermedizin, JLU Giessen) for kindly providing bacterial isolates.
One of us (A.A.) was supported by a grant from the Impfstoffwerk
Dessau-Tornau, Rosslau Germany.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institut fuer
Mikrobiologie und Tierseuchen, Tieraerztliche Hochschule Hannover,
Bischofsholer Damm 15, 30171 Hannover, Germany. Phone:
49-511 9537362. Fax: 49-511 9537697. E-mail:
pvalenti{at}micro.tiho-hannover.de.
 |
REFERENCES |
| 1.
|
Arends, J. P., and H. C. Zanen.
1988.
Meningitis caused by Streptococcus suis in humans.
Rev. Infect. Dis.
10:131-137[Medline].
|
| 2.
|
Chanter, N.,
P. W. Jones, and T. J. L. Alexander.
1993.
Meningitis in pigs caused by Streptococcus suis a speculative review.
Vet. Microbiol.
36:39-55[CrossRef][Medline].
|
| 3.
|
Charland, N.,
V. Nizet,
C. E. Rubens,
K. S. Kim,
S. Lacouture, and M. Gottschalk.
2000.
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells.
Infect. Immun.
68:637-643[Abstract/Free Full Text].
|
| 4.
|
Chatellier, S.,
M. Gottschalk,
R. Higgins,
R. Brousseau, and J. Harel.
1999.
Relatedness of Streptococcus suis serotype 2 isolates from different geographic origins as evaluated by molecular fingerprinting and phenotyping.
J. Clin. Microbiol.
37:362-366[Abstract/Free Full Text].
|
| 5.
|
Clifton-Hadley, F. A.
1986.
The epidemiology, diagnosis, treatment and control of Streptococcus suis type 2 infection, p. 471-491.
In
J. D. McKean (ed.), Proceedings of the American Association of Swine Practioners. American Association of Swine Practioners, Minneapolis, Minn.
|
| 6.
|
Clifton-Hadley, F. A, and T. J. L. Alexander.
1980.
The carrier site and carrier rate of Streptococcus suis type II in pigs.
Vet. Rec.
107:40-41[Medline].
|
| 7.
|
Esteopangestie, S., and C. Laemmler.
1993.
Distribution of capsular types 1 to 28 and further characteristics of Streptococcus suis isolates from various European countries.
Zentbl. Bakteriol. Parasitenkd. Infektkrank. Hyg. Abt. 1 Orig.
279:394-403.
|
| 8.
|
Gottschalk, M.,
R. Higgins, and M. Jacques.
1993.
Production of capsular material by Streptococcus suis serotype 2 under different growth conditions.
Can. J. Vet. Res.
57:49-52[Medline].
|
| 9.
|
Gottschalk, M.,
S. Petitbois,
R. Higgins, and M. Jaques.
1991.
Adherence of Streptococcus suis capsular type 2 to porcine lung sections.
Can. J. Vet. Res.
55:302-304[Medline].
|
| 10.
|
Gottschalk, M.,
S. Lacouture, and J. D. Dubreull.
1995.
Characterization of Streptococcus suis capsular type 2 haemolysin.
Microbiology
141:189-195[Abstract/Free Full Text].
|
| 11.
|
Gottschalk, M.,
A. Lebrun,
H. J. Wisselink,
J. D. Dubreuil,
H. E. Smith, and U. Vecht.
1998.
Production of virulence-related proteins by Canadian strains of Streptococcus suis capsular type 2.
Can. J. Vet. Res.
62:75-79[Medline].
|
| 12.
|
Hampson, D. J.,
D. J. Trott,
I. L. Clarke,
C. G. Mwaniki, and I. D. Robertson.
1993.
Population structure of Australian isolates of Streptococcus suis.
J. Clin. Microbiol.
31:2895-2900[Abstract/Free Full Text].
|
| 13.
|
Harel, J.,
R. Higgins,
M. Gottschalk, and M. Bigras-Poulin.
1994.
Genomic relatedness among reference strains of different Streptococcus suis serotypes.
Can. J. Vet. Res.
58:259-262[Medline].
|
| 14.
|
Hoefling, D. C.
1998.
Tracking the incidence of porcine respiratory diseases.
Vet. Med.
93:391-398.
|
| 15.
|
Jacobs, A. A. C.,
P. L. W. Loeffen,
A. J. G. Van Den Berg, and P. K. Storm.
1994.
Identification, purification, and characterization of a thiol-activated hemolysin (suilysin) of Streptococcus suis.
Infect. Immun.
62:1742-1748[Abstract/Free Full Text].
|
| 16.
|
Jacobs, A. A. C.,
A. J. G. Van Den Berg,
J. C. Baars,
B. Nielsen, and L. W. Johannsen.
1995.
Production of suilysin, the thiol-activated haemolysin of Streptococcus suis, by field isolates from diseased pigs.
Vet. Rec.
139:295-296.
|
| 17.
|
Jacobs, A. A. C.,
A. J. G. Van Den Berg, and P. L. W. Loeffen.
1996.
Protection of experimentally infected pigs by suilysin, the thiol-activated haemolysin of Streptococcus suis.
Vet. Rec.
139:225-228[Abstract/Free Full Text].
|
| 18.
|
Macinnes, J. I., and R. Desrosiers.
1999.
Agents of the "suis-ide diseases" of swine: Actinobacillus suis, Haemophilus suis, and Streptococcus suis.
Can. J. Vet. Res.
63:83-89[Medline].
|
| 19.
|
Mogollon, J. D.,
C. Pijoan,
M. P. Murtaugh,
J. E. Collins, and P. P. Cleary.
1991.
Identification of epidemic strains of Streptococcus suis by genomic fingerprinting.
J. Clin. Microbiol.
29:782-787[Abstract/Free Full Text].
|
| 20.
|
Mwaniki, C. G.,
I. D. Robertson,
D. J. Trott,
R. F. Atyeo,
B. J. Lee, and D. J. Hampson.
1994.
Clonal analysis and virulence of Australian isolates of Streptococcus suis type 2.
Epidemiol. Infect.
113:321-334[Medline].
|
| 21.
|
Okwumabua, O.,
J. Staats, and M. M. Chengappa.
1995.
Detection of genomic heterogeneity in Streptococcus suis isolates by DNA restriction fragment length polymorphism of rRNA genes (ribotyping).
J. Clin. Microbiol.
4:968-972.
|
| 22.
|
Olsen, J. E., and M. Skov.
1984.
Genomic lineage of Salmonella enterica serovar Dublin.
Vet. Microbiol.
40:271-282.
|
| 23.
|
Rasmussen, S. R.,
F. M. Aarestrup,
N. E. Jensen, and S. E. Jorsasl.
1999.
Associations of Streptococcus suis serotype 2 ribotype profiles with clinical disease and antimicrobial resistance.
J. Clin. Microbiol.
37:404-408[Abstract/Free Full Text].
|
| 24.
|
Reams, R. Y.,
D. D. Harrington,
L. T. Glickman,
H. L. Thacker, and T. L. Bowersock.
1996.
Multiple serotypes and strains of Streptococcus suis in naturally infected swine herds.
J. Vet. Diagn. Investig.
8:119-121[Free Full Text].
|
| 25.
|
Smith, H. E.,
M. Damman,
J. Van Der Velde,
F. Wagenaar,
H. J. Wisselink,
N. Stockhofe-Zurwieden, and M. A. Smits.
1999.
Identification and characterization of the cps locus of Streptococcus suis serotype 2: the capsule protects against phagocytosis and is an important virulence factor.
Infect. Immun.
67:1750-1756[Abstract/Free Full Text].
|
| 26.
|
Smith, H. E.,
M. Rijnsburger,
N. Stockhofe-Zurwieden,
H. J. Wisselink,
U. Vecht, and M. A. Smits.
1997.
Virulent strains of Streptococcus suis serotype 2 and highly virulent strains of Streptococcus suis serotype 1 can be recognized by a unique ribotype profile.
J. Clin. Microbiol.
35:1049-1053[Abstract].
|
| 27.
|
Smith, H. E.,
U. Vecht,
A. L. J. Gielkens, and M. A. Smits.
1996.
Cloning and nucleotide sequence of the gene encoding the 136-kilodalton surface protein (muraminidase-released protein) of Streptococcus suis type 2.
Infect. Immun.
60:2361-2367[Abstract/Free Full Text].
|
| 28.
|
Smith, H. E.,
U. Vecht,
H. J. Wisselink,
N. Stockhofe-Zurwieden,
Y. Biermann, and M. A. Smits.
1996.
Mutants of Streptococcus suis types 1 and 2 impaired in expression of muramidase-released protein and extracellular protein induce disease in newborn germfree pigs.
Infect. Immun.
64:4409-4412[Abstract].
|
| 29.
|
Staats, J. J.,
B. L. Plattner,
J. Nietfeld,
S. Dritz, and M. M. Chengappa.
1998.
Use of ribotyping and hemolysin activity to identify highly virulent Streptococcus suis type 2 isolates.
J. Clin. Microbiol.
36:15-19[Abstract/Free Full Text].
|
| 30.
|
Suvrov, A. N., and J. J. Ferretti.
1996.
Physical and genetic map of an M type 1 strain of Streptococcus pyogenes.
J. Bacteriol.
178:5546-5549[Abstract/Free Full Text].
|
| 31.
|
Talay, S. R.,
P. Valentin-Weigand,
P. G. Jerlstroem,
K. N. Timmis, and G. S. Chhatwal.
1992.
Fibronectin binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells.
Infect. Immun.
60:3837-3844[Abstract/Free Full Text].
|
| 32.
|
Tikkanen, K.,
S. Haataja, and J. Finne.
1996.
The galactosyl-(1-4)-galactose-binding adhesin of Streptococcus suis: occurrence in strains of different hemagglutination activities and induction of opsonic antibodies.
Infect. Immun.
64:3659-3665[Abstract].
|
| 33.
|
Vecht, U.,
J. P. Arends,
E. J. Van Der Molen, and L. A. M. G. Van Leengoed.
1989.
Differences in virulence between two strains of Streptococcus suis type II after experimentally induced infection of newborn germ-free pigs.
Am. J. Vet. Res.
50:1037-1043[Medline].
|
| 34.
|
Vecht, U.,
N. Stockhofe-Zurwieden,
B. J. Tetenburg,
H. J. Wisselink, and H. E. Smith.
1997.
Virulence of Streptococcus suis type 2 for mice and pigs appeared host-specific.
Vet. Microbiol.
58:53-60[CrossRef][Medline].
|
| 35.
|
Vecht, U.,
H. J. Wisselink,
M. L. Jellema, and H. E. Smith.
1991.
Identification of two proteins associated with virulence of Streptococcus suis type 2.
Infect. Immun.
59:3156-3162[Abstract/Free Full Text].
|
| 36.
|
Wisselink, H. J.,
H. E. Smith,
N. Stockhofe-Zurwieden,
K. Peperkamp, and U. Vecht.
2000.
Distribution of capsular types and production of murimidase-released protein (MRP) and extracellular factor (EF) of Streptococcus suis isolated from diseased pigs in seven European countries.
Vet. Microbiol.
74:237-248[CrossRef][Medline].
|
Journal of Clinical Microbiology, February 2001, p. 445-453, Vol. 39, No. 2
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.2.445-453.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Baums, C. G., Verkuhlen, G. J., Rehm, T., Silva, L. M. G., Beyerbach, M., Pohlmeyer, K., Valentin-Weigand, P.
(2007). Prevalence of Streptococcus suis Genotypes in Wild Boars of Northwestern Germany. Appl. Environ. Microbiol.
73: 711-717
[Abstract]
[Full Text]
-
Rehm, T., Baums, C. G., Strommenger, B., Beyerbach, M., Valentin-Weigand, P., Goethe, R.
(2007). Amplified fragment length polymorphism of Streptococcus suis strains correlates with their profile of virulence-associated genes and clinical background. J Med Microbiol
56: 102-109
[Abstract]
[Full Text]
-
Baums, C. G., Kaim, U., Fulde, M., Ramachandran, G., Goethe, R., Valentin-Weigand, P.
(2006). Identification of a Novel Virulence Determinant with Serum Opacification Activity in Streptococcus suis.. Infect. Immun.
74: 6154-6162
[Abstract]
[Full Text]
-
Gruening, P., Fulde, M., Valentin-Weigand, P., Goethe, R.
(2006). Structure, Regulation, and Putative Function of the Arginine Deiminase System of Streptococcus suis. J. Bacteriol.
188: 361-369
[Abstract]
[Full Text]
-
King, S. J., Allen, A. G., Maskell, D. J., Dowson, C. G., Whatmore, A. M.
(2004). Distribution, Genetic Diversity, and Variable Expression of the Gene Encoding Hyaluronate Lyase within the Streptococcus suis Population. J. Bacteriol.
186: 4740-4747
[Abstract]
[Full Text]
-
Harel, J., Martinez, G., Nassar, A., Dezfulian, H., Labrie, S. J., Brousseau, R., Moineau, S., Gottschalk, M.
(2003). Identification of an Inducible Bacteriophage in a Virulent Strain of Streptococcus suis Serotype 2. Infect. Immun.
71: 6104-6108
[Abstract]
[Full Text]
-
Vela, A. I., Goyache, J., Tarradas, C., Luque, I., Mateos, A., Moreno, M. A., Borge, C., Perea, J. A., Dominguez, L., Fernandez-Garayzabal, J. F.
(2003). Analysis of Genetic Diversity of Streptococcus suis Clinical Isolates from Pigs in Spain by Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
41: 2498-2502
[Abstract]
[Full Text]
-
Winterhoff, N., Goethe, R., Gruening, P., Rohde, M., Kalisz, H., Smith, H. E., Valentin-Weigand, P.
(2002). Identification and Characterization of Two Temperature-Induced Surface-Associated Proteins of Streptococcus suis with High Homologies to Members of the Arginine Deiminase System of Streptococcus pyogenes. J. Bacteriol.
184: 6768-6776
[Abstract]
[Full Text]
-
King, S. J., Leigh, J. A., Heath, P. J., Luque, I., Tarradas, C., Dowson, C. G., Whatmore, A. M.
(2002). Development of a Multilocus Sequence Typing Scheme for the Pig Pathogen Streptococcus suis: Identification of Virulent Clones and Potential Capsular Serotype Exchange. J. Clin. Microbiol.
40: 3671-3680
[Abstract]
[Full Text]
-
Wisselink, H. J., Joosten, J. J., Smith, H. E.
(2002). Multiplex PCR Assays for Simultaneous Detection of Six Major Serotypes and Two Virulence-Associated Phenotypes of Streptococcus suis in Tonsillar Specimens from Pigs. J. Clin. Microbiol.
40: 2922-2929
[Abstract]
[Full Text]
-
Takamatsu, D., Osaki, M., Sekizaki, T.
(2002). Evidence for Lateral Transfer of the Suilysin Gene Region of Streptococcus suis. J. Bacteriol.
184: 2050-2057
[Abstract]
[Full Text]
-
de Greeff, A., Buys, H., Verhaar, R., Dijkstra, J., van Alphen, L., Smith, H. E.
(2002). Contribution of Fibronectin-Binding Protein to Pathogenesis of Streptococcus suis Serotype 2. Infect. Immun.
70: 1319-1325
[Abstract]
[Full Text]
-
Berthelot-Herault, F., Marois, C., Gottschalk, M., Kobisch, M.
(2002). Genetic Diversity of Streptococcus suis Strains Isolated from Pigs and Humans as Revealed by Pulsed-Field Gel Electrophoresis. J. Clin. Microbiol.
40: 615-619
[Abstract]
[Full Text]
-
King, S. J., Heath, P. J., Luque, I., Tarradas, C., Dowson, C. G., Whatmore, A. M.
(2001). Distribution and Genetic Diversity of Suilysin in Streptococcus suis Isolated from Different Diseases of Pigs and Characterization of the Genetic Basis of Suilysin Absence. Infect. Immun.
69: 7572-7582
[Abstract]
[Full Text]
-
Sekizaki, T., Osaki, M., Takamatsu, D., Shimoji, Y.
(2001). Distribution of the SsuDAT1I Restriction-Modification System among Different Serotypes of Streptococcus suis. J. Bacteriol.
183: 5436-5440
[Abstract]
[Full Text]